Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples

Keertan Dheda, Virginia Davids, Laura Lenders et al. · 2010

Read Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples by Keertan Dheda, Virginia Davids, Laura Lenders et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009848.txt.

Description

Tuberculosis is hard to confirm quickly in patients who also carry HIV. Keertan Dheda and colleagues tested a commercial urine and sputum test for that job. Their study appeared in PLOS ONE in 2010. Urine is far easier to collect than most samples.

The test is a LAM-ELISA assay, which hunts for a molecule shed by TB bacteria. Clinical utility means whether a test actually helps real diagnosis. The team judged the assay in HIV-infected patients, whose TB often hides. A fast, simple test would matter most where labs are scarce.

Catalog record

CREATORKeertan Dheda, Virginia Davids, Laura Lenders et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009848

Browse the full library · About the Tower of Babel